A Different Approach to Dermatology Care

Brian Hillberdink, EVP, LEO Pharma and President of LEO Pharma's US affiliate, discusses:

• How they're positioning the company to capitalize on the unmet needs in other specific therapeutic areas
• Strategies to ensure long-term success in these spaces
• Patient centric initiatives they've implemented to ensure the patient voice is integrated into drug development and commercialization processes
• Their approach to orphan drug development
• Challenges and opportunities adapting to the US market